Inventor · disambiguated record
Sriram Sathyanarayanan
Also filed as: SATHYANARAYANAN SRIRAM
11 granted patents·24 pending applications·42 citations·filing 2000–2025
88Inventor score
Files withCODIAK BIOSCIENCES INC12JOUNCE THERAPEUTICS INC9LONZA SALES AG7SATHYANARAYANAN SRIRAM4GEN HOSPITAL CORP2
Top patents by PatentIndex Score
35 records- 0193US10723782B2Exosomes for immuno-oncology and anti-inflammatory therapyCODIAK BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·9 cites·19 claims
- 0291US12331100B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0389US10626176B2Methods of treating conditions with antibodies that bind B7-H4JOUNCE THERAPEUTICS INC·Filed 2015·Granted Apr 21, 2020·8 cites·2 claims
- 0487US10023635B2Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·8 cites·47 claims
- 0583US12030924B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2020·Granted Jul 9, 2024·1 cites·18 claims
- 0682US10570203B2Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·3 cites·24 claims
- 0780US11512315B2Methods and compositions for macrophage polarizationCODIAK BIOSCIENCES INC·Filed 2019·Granted Nov 29, 2022·3 cites·9 claims
- 0880US10968277B2Gene signatures for determining ICOS expressionJOUNCE THERAPEUTICS INC·Filed 2016·Granted Apr 6, 2021·2 cites·21 claims
- 0977US2025296980A1Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2025·Application pending·0 cites
- 1076US8852590B2Compositions and methods for treating cancerSATHYANARAYANAN SRIRAM·Filed 2010·Granted Oct 7, 2014·3 cites·1 claims
- 1164US2021171635A1Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1263US2024254481A1Extracellular vesicle-aso constructs targeting stat6LONZA SALES AG·Filed 2022·Application pending·0 cites
- 1360US2022281978A1Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)JOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1458US6475744B1Methods for identifying compounds which modulate circadian rhythmGEN HOSPITAL CORP·Filed 2000·Granted Nov 5, 2002·4 cites·33 claims
- 1557US2021340256A1Gene Signatures for Determining ICOS ExpressionJOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1653US2025115904A1Extracellular vesicle-aso constructs targeting stat6CODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1751US2023114434A1Extracellular vesicles for treating neurological disordersCODIAK BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1850US2025114445A1Extracellular vesicles for therapyLONZA SALES AG·Filed 2021·Application pending·0 cites
- 1949US2022395465A1Sting agonist comprising exosomes combined with il-12 displaying exosomes for treating a tumourCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2049US2023193274A1Extracellular vesicles with stat3-antisense oligonucleotidesCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2148US2015056191A1Igf1 biomarker for igf1r inhibitor therapyMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2248US2023181758A1Extracellular vesicles targeting dendritic cells and uses thereofCODIAK BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2348US2023132093A1Extracellular vesicle-nlrp3 antagonistCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2448US2024108747A1Extracellular vesicle conjugates and uses thereofLONZA SALES AG·Filed 2020·Application pending·0 cites
- 2548US2025249072A1Methods of treating cancerLONZA SALES AG·Filed 2021·Application pending·0 cites
- 2647US2022251200A1Extracellular vesicles targeting t cells and uses thereofCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2746US2023018254A1Extracellular vesicles with antisense oligonucleotides targeting krasCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2846US2023002764A1Extracellular vesicle-aso constructs targeting cebp/betaCODIAK BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2945US2020024351A1Compositions and Methods for the Treatment of CancerJOUNCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3041US2003059848A1Methods for identifying compounds which modulate circadian rhythmGEN HOSPITAL CORP·Filed 2002·Application pending·0 cites
- 3139US9110082B2Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapySATHYANARAYANAN SRIRAM·Filed 2010·Granted Aug 18, 2015·0 cites·12 claims
- 3239US2021322327A1Extracellular vesicles comprising sting-agonistCODIAK BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3339US2013287763A1Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitorSATHYANARAYANAN SRIRAM·Filed 2011·Application pending·0 cites
- 3431US2016200815A1Antibodies that inhibit tim-3:lilrb2 interactions and uses thereofJOUNCE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3528US2012058112A1AntibodiesSATHYANARAYANAN SRIRAM·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sriram Sathyanarayanan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →